How can we help?
BRCAMap - Germline

BRCAMap - Germline near me in Kattupakkam

For men & women
Earliest reports in
888 hours
Contains
1 test
Know more about this test

The BRCAMap - Germline test identifies inherited mutations in the BRCA1 and BRCA2 genes. It helps assess the risk of developing breast, ovarian, prostate, and pancreatic cancers in individuals and their family members. This test supports early detection, proactive monitoring, and personalized preventive or treatment strategies.

Samples required
Blood
Find out
Why is this test booked?
Preparation for this test
Sample Collection
Who will collect your samples?

Understanding BRCAMap - Germline

Breast cancer is a significant health concern worldwide, affecting nearly 12% of women in the general population. In India, the incidence is even higher, with 1 in 28 women diagnosed in their lifetime. The BRCA1 and BRCA2 genes play a critical role in maintaining DNA integrity and preventing uncontrolled cell growth. Mutations in these genes compromise DNA repair mechanisms, leading to an increased risk of breast, ovarian, prostate, and pancreatic cancers.

BRCAMap - Germline test is a targeted next-generation sequencing (NGS) panel designed to detect pathogenic or likely pathogenic mutations in BRCA1 and BRCA2. The test covers the entire coding region of both genes, enabling the detection of a wide range of genetic alterations, including point mutations, small insertions/deletions, and large rearrangements. This comprehensive evaluation allows for accurate risk assessment in individuals with a personal or family history of cancer.

The test is performed on germline samples (blood) to assess inherited risk in unaffected individuals. It helps identify whether mutations in BRCA genes are present, enabling early monitoring, preventive measures, and informed clinical management decisions.

Doctors may recommend the BRCAMap - Germline for individuals who have a strong family history of breast, ovarian, fallopian tube, peritoneal, prostate, or pancreatic cancer. It is also advised for those with a personal history of breast or ovarian cancer, particularly if diagnosed at a young age, with bilateral cancers, or rare subtypes. Individuals of Ashkenazi Jewish or Eastern European descent may be considered for testing due to a higher prevalence of BRCA mutations in these populations. The test is relevant for male breast cancer patients as well as for anyone with known BRCA1 or BRCA2 mutations in their family.

For this test, it is important to submit the clinical history, histopathology report, previous test results, and a doctor’s prescription at the time of sample collection. The Tata 1mg consolidated Test Requisition Form (TRF) must also be duly filled and submitted along with the bone marrow sample.

Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results.

Note: Post-test genetic counseling can be provided. If interested, please send the request to this email id: [email protected]      

See more

What does BRCAMap - Germline measure?

The BRCAMap - Germline test detects inherited mutations in the BRCA1 and BRCA2 genes using next-generation sequencing (NGS). These genes play a vital role in repairing DNA and suppressing tumor development, and mutations in them can increase the risk of breast, ovarian, prostate, and pancreatic cancers. By identifying pathogenic or likely pathogenic variants, the test provides an assessment of hereditary cancer risk for both patients and their family members. It also offers guidance for preventive strategies, enhanced screening, and early interventions, while supporting genetic counseling and informed family planning decisions. Additionally, the test provides valuable information for personalized treatment planning, including the use of targeted therapies such as PARP inhibitors. This focused evaluation enables doctors to tailor care, initiate early monitoring, and manage hereditary cancer risk effectively.

BRCAMap - Germline test price for other cities

Price inBangaloreRs. 13770
Price inNavi MumbaiRs. 13770
Price inKolkataRs. 13770
Price inAllahabadRs. 13770
Price inBhopalRs. 13770

How does home sample collection work?

Download the Tata 1mg app. Trusted healthcare, at your fingertips.

Book tests, track reports, and get AI-powered health insights.

or

Other tests

Test conducted by
Mapmygenome India Limited
NABL, ISO certified
Know More
Contains 1 test
BRCAMap - Germline